- The Future Path for the JKMA
-
Lee C
- KMID: 2183057
- J Korean Med Assoc.
- 2003 Jan;46(1):3-3.
- doi: 10.5124/jkma.2003.46.1.3
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A New Year's Greeting Message
-
Shin SJ
- KMID: 2183056
- J Korean Med Assoc.
- 2003 Jan;46(1):2-2.
- doi: 10.5124/jkma.2003.46.1.2
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- With High hopes for Reverse of the JKMA
-
Hahm CK
- KMID: 2183058
- J Korean Med Assoc.
- 2003 Jan;46(1):4-5.
- doi: 10.5124/jkma.2003.46.1.4
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnosis and Treatment of Female Sexual Dysfunction
-
Yoon HN
- KMID: 2183065
- J Korean Med Assoc.
- 2003 Jan;46(1):51-55.
- doi: 10.5124/jkma.2003.46.1.51
Woman's sexual response is composite and complex. However, recent understanding of the causes of sexual dysfunction in women highlights not only psychological but also organic aspects. Taking patients' medical and... -
- CITED
-
- Close
- SHARE
-
- Close
- Passive Smoking and Lung Cancer
-
Hwang BB
- KMID: 2183060
- J Korean Med Assoc.
- 2003 Jan;46(1):12-20.
- doi: 10.5124/jkma.2003.46.1.12
Active smoking is a major cause of lung cancer. The dose-response relation between exposure to tobacco smoke and risk of lung cancer is almost linear. No threshold level is apparent... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacological Treatment of Depression
-
Lee MS
- KMID: 2183067
- J Korean Med Assoc.
- 2003 Jan;46(1):69-75.
- doi: 10.5124/jkma.2003.46.1.69
This paper is to summarize the specific form of pharmacological treatments that have been developed to deal with depressive disorder. Specific antidepressants including monoamine oxidase inhibitors(MAOIs), tricyclic antidepressants(TCAs), selective serotonin... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular Targeted Therapy for Lung Cancer
-
Heo DS
- KMID: 2183064
- J Korean Med Assoc.
- 2003 Jan;46(1):46-50.
- doi: 10.5124/jkma.2003.46.1.46
Lung cancer is a leading cause of cancer deaths in Korea. In spite of some improvements, conventional treatments (surgery, radiotherapy and chemotherapy) did not bring satisfactory solution of this fatal... -
- CITED
-
- Close
- SHARE
-
- Close
- Lung Cancer: Overview
-
Lee JS
- KMID: 2183059
- J Korean Med Assoc.
- 2003 Jan;46(1):7-11.
- doi: 10.5124/jkma.2003.46.1.7
Lung cancer became a leading cause of cancer deaths in Korea in 2000. It is an anticipated result of cigarette smoking which was very prevalent among Korean males over the... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy in Lung Cancer
-
Park KC
- KMID: 2183063
- J Korean Med Assoc.
- 2003 Jan;46(1):38-45.
- doi: 10.5124/jkma.2003.46.1.38
Non-small cell lung cancer: As most patients with non-small cell lung cancer present with nonsurgically curable diseae, major efforts have been made in the treatment of advanced non-small cell lung... -
- CITED
-
- Close
- SHARE
-
- Close
- The Advantage of UFT in the Patients with Stage IA & IB Lung Cancer after Complete Resection
-
Lee DY
- KMID: 2183061
- J Korean Med Assoc.
- 2003 Jan;46(1):21-28.
- doi: 10.5124/jkma.2003.46.1.21
Despite complete resection of tumor and mediastinal lymph node dissection, the post-operative survival rate of early stage I non-small cell carcinoma is not so good due to increased recurrences. So,... -
- CITED
-
- Close
- SHARE
-
- Close
- Pancreatitis
-
Kim CD
- KMID: 2183066
- J Korean Med Assoc.
- 2003 Jan;46(1):56-66.
- doi: 10.5124/jkma.2003.46.1.56
Pancreatic inflammatory disease may be classified as acute pancreatitis(AP) and chronic pancreatitis(CP) by primarily clinical criteria, with the obvious difference between them being restoration of normal function in the former... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiotherapy for Locally Advanced Lung Cancer
-
Choi EK
- KMID: 2183062
- J Korean Med Assoc.
- 2003 Jan;46(1):29-37.
- doi: 10.5124/jkma.2003.46.1.29
Lung cancer is the leading cause of cancer deaths. Non-small cell lung cancer constitutes approximately 75% of lung cancers, and 40% present as advanced stage III a or III b,... -
- CITED
-
- Close
- SHARE
-
- Close
